| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.19 | 1e-05 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |